Lista de obras -

A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis

artículo científico publicado en 2016

A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status

artículo científico publicado en 2020

Armed conflict and population displacement as drivers of the evolution and dispersal of Mycobacterium tuberculosis

artículo científico publicado en 2016

Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country

artículo científico publicado en 2012

Assessing tuberculosis control priorities in high-burden settings: a modelling approach

scientific article published on 20 March 2019

Benchmarking the empirical accuracy of short-read sequencing across the<i>M. tuberculosis</i>genome

artículo científico publicado en 2022

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

scientific article published on 20 March 2019

Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.

artículo científico publicado en 2018

Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection

artículo científico publicado en 2015

Cost analysis of rapid diagnostics for drug-resistant tuberculosis.

artículo científico publicado en 2018

Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries

artículo científico publicado en 2014

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

artículo científico publicado en 2015

FATE: the new partnership to Fight Against TB in Central and Eastern Europe.

artículo científico publicado en 2017

Failing treatment of multidrug-resistant tuberculosis: a matter of definition

scientific article published on 01 April 2019

First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances

artículo científico publicado en 2012

Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape

artículo científico publicado en 2016

Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis.

artículo científico publicado en 2013

High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova ⬇️

artículo científico publicado en 2014

High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova.

artículo científico publicado en 2017

Increasing tuberculosis case detection: lessons from the Republic of Moldova

artículo científico publicado en 2008

Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the katG 315T mutation.

artículo científico publicado en 2017

MDR-TB in Eastern Europe in the era of the TB elimination action framework

artículo científico publicado en 2017

MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis.

artículo científico publicado en 2016

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

artículo científico publicado en 2014

Molecular Detection of <i>Mycobacterium tuberculosis</i> in Oral Mucosa from Patients with Presumptive Tuberculosis

artículo científico publicado en 2020

Multidrug-resistant tuberculosis in Europe, 2010-2011

artículo científico publicado en 2015

Nosocomial transmission of multidrug-resistant tuberculosis

artículo científico publicado en 2015

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.

artículo científico publicado en 2015

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis

artículo científico publicado en 2015

Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.

artículo científico publicado en 2015

Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.

artículo científico publicado en 2015

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations

artículo científico publicado en 2014

Publisher's expression of concern: geographical differences associated with SNPs in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis

artículo científico publicado en 2013

Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study

artículo científico publicado en 2016

Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova

artículo científico publicado en 2013

Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay

artículo científico publicado en 2014

Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.

artículo científico publicado en 2016

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis

artículo científico publicado en 2014

The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis.

artículo científico publicado en 2017

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

artículo científico publicado en 2016

Treatment outcomes of MDR-TB and HIV co-infection in Europe

artículo científico publicado en 2017

Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.

artículo científico publicado en 2017

Lista de obras de

A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis

A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status

Armed conflict and population displacement as drivers of the evolution and dispersal of Mycobacterium tuberculosis

Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country

Assessing tuberculosis control priorities in high-burden settings: a modelling approach

Benchmarking the empirical accuracy of short-read sequencing across the<i>M. tuberculosis</i>genome

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.

Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection

Cost analysis of rapid diagnostics for drug-resistant tuberculosis.

Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

FATE: the new partnership to Fight Against TB in Central and Eastern Europe.

Failing treatment of multidrug-resistant tuberculosis: a matter of definition

First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances

Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape

Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis.

High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova ⬇️

High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova.

Increasing tuberculosis case detection: lessons from the Republic of Moldova

Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the katG 315T mutation.

MDR-TB in Eastern Europe in the era of the TB elimination action framework

MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

Molecular Detection of <i>Mycobacterium tuberculosis</i> in Oral Mucosa from Patients with Presumptive Tuberculosis

Multidrug-resistant tuberculosis in Europe, 2010-2011

Nosocomial transmission of multidrug-resistant tuberculosis

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis

Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.

Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations

Publisher's expression of concern: geographical differences associated with SNPs in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis

Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study

Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova

Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay

Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis

The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis.

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Treatment outcomes of MDR-TB and HIV co-infection in Europe

Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.